Stuart P. Ballantine

816 total citations
13 papers, 603 citations indexed

About

Stuart P. Ballantine is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Stuart P. Ballantine has authored 13 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Stuart P. Ballantine's work include Phosphodiesterase function and regulation (4 papers), Receptor Mechanisms and Signaling (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Stuart P. Ballantine is often cited by papers focused on Phosphodiesterase function and regulation (4 papers), Receptor Mechanisms and Signaling (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Stuart P. Ballantine collaborates with scholars based in United Kingdom, Canada and United States. Stuart P. Ballantine's co-authors include David H. Boxer, Chris J. Delves, Filippo Volpe, Andrew Makoff, Frank Sargent, Neil F. Fairweather, Tracy Palmer, Don O. Somers, Margarete Neu and Michael Kranz and has published in prestigious journals such as Nature Biotechnology, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Stuart P. Ballantine

13 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart P. Ballantine United Kingdom 12 329 155 135 91 68 13 603
Jon T. Roll United States 10 159 0.5× 31 0.2× 138 1.0× 47 0.5× 107 1.6× 12 577
Yanan Niu China 15 278 0.8× 64 0.4× 14 0.1× 33 0.4× 57 0.8× 55 876
Dorothea Kessler Germany 8 364 1.1× 29 0.2× 194 1.4× 23 0.3× 21 0.3× 9 555
Yumnam Silla India 11 134 0.4× 36 0.2× 39 0.3× 25 0.3× 10 0.1× 13 314
Zepeng Qu China 11 308 0.9× 25 0.2× 89 0.7× 89 1.0× 5 0.1× 21 560
José Luis Castrejón-Flores Mexico 13 110 0.3× 59 0.4× 25 0.2× 206 2.3× 22 0.3× 27 505
Vivi Joosten Netherlands 8 396 1.2× 27 0.2× 16 0.1× 30 0.3× 11 0.2× 9 607
Joo‐Hong Park South Korea 15 408 1.2× 22 0.1× 13 0.1× 184 2.0× 56 0.8× 32 658
Adrienne C. Dlouhy United States 8 235 0.7× 27 0.2× 80 0.6× 10 0.1× 68 1.0× 8 452

Countries citing papers authored by Stuart P. Ballantine

Since Specialization
Citations

This map shows the geographic impact of Stuart P. Ballantine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart P. Ballantine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart P. Ballantine more than expected).

Fields of papers citing papers by Stuart P. Ballantine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart P. Ballantine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart P. Ballantine. The network helps show where Stuart P. Ballantine may publish in the future.

Co-authorship network of co-authors of Stuart P. Ballantine

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart P. Ballantine. A scholar is included among the top collaborators of Stuart P. Ballantine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart P. Ballantine. Stuart P. Ballantine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mitchell, Charlotte, Stuart P. Ballantine, Diane M. Coe, et al.. (2010). Pyrazolopyridines as potent PDE4B inhibitors: 5-Heterocycle SAR. Bioorganic & Medicinal Chemistry Letters. 20(19). 5803–5806. 34 indexed citations
2.
Ward, Simon E., Mark H Harries, Laura Aldegheri, et al.. (2010). Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of AMPA Receptor Positive Allosteric Modulators. Journal of Medicinal Chemistry. 54(1). 78–94. 57 indexed citations
3.
Woodrow, Michael D., Stuart P. Ballantine, Michael D. Barker, et al.. (2009). Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration. Bioorganic & Medicinal Chemistry Letters. 19(5). 1380–1385. 54 indexed citations
4.
Kranz, Michael, Michael Wall, Afjal H. Miah, et al.. (2009). Identification of PDE4B Over 4D subtype-selective inhibitors revealing an unprecedented binding mode. Bioorganic & Medicinal Chemistry. 17(14). 5336–5341. 52 indexed citations
5.
Hamblin, J., Stuart P. Ballantine, Anthony W. J. Cooper, et al.. (2008). Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4237–4241. 59 indexed citations
6.
Sargent, Frank, et al.. (1998). Reassignment of the gene encoding the Escherichia coli hydrogenase 2 small subunit. European Journal of Biochemistry. 255(3). 746–754. 68 indexed citations
7.
Thomas, M. Carmen, et al.. (1998). Single Amino Acid Substitutions Disrupt Tetramer Formation in the Dihydroneopterin Aldolase Enzyme of Pneumocystis carinii. Biochemistry. 37(33). 11629–11636. 11 indexed citations
8.
9.
Kellam, Paul, W S Dallas, Stuart P. Ballantine, & Chris J. Delves. (1995). Functional cloning of the dihydropteroate synthase gene ofStaphylococcus haemolyticus. FEMS Microbiology Letters. 134(2-3). 165–169. 12 indexed citations
10.
Volpe, Filippo, Stuart P. Ballantine, & Chris J. Delves. (1993). The multifunctional folic acid synthesis fas gene of Pneumocystis carinii encodes dihydroneopterin aldolase, hydroxymethyldihydropterin pyrophosphokinase and dihydropteroate synthase. European Journal of Biochemistry. 216(2). 449–458. 55 indexed citations
11.
Makoff, Andrew, et al.. (1989). Expression of Tetanus Toxin Fragment C in E. coli: Its Purification and Potential Use as a Vaccine. Nature Biotechnology. 7(10). 1043–1046. 56 indexed citations
12.
Ballantine, Stuart P. & David H. Boxer. (1986). Isolation and characterisation of a soluble active fragment of hydrogenase isoenzyme 2 from the membranes of anaerobically grown Escherichia coli. European Journal of Biochemistry. 156(2). 277–284. 121 indexed citations
13.
Ballantine, Stuart P., et al.. (1986). Identification of a membrane-bound hydrogenase of Desulfovibrio vulgaris (Hildenborough). Biochimica et Biophysica Acta (BBA) - Bioenergetics. 851(1). 57–64. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jon T. Roll Breakdown of academic impact, for papers by Yanan Niu Breakdown of academic impact, for papers by Dorothea Kessler Breakdown of academic impact, for papers by Yumnam Silla Breakdown of academic impact, for papers by Zepeng Qu Breakdown of academic impact, for papers by José Luis Castrejón-Flores Breakdown of academic impact, for papers by Vivi Joosten Breakdown of academic impact, for papers by Joo‐Hong Park Breakdown of academic impact, for papers by Adrienne C. Dlouhy
Rankless by CCL
2026